| |
| |
|
| Insider
Information: |
Tulipano Stephen J |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
29,309 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$35,622 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
29,309 |
|
|
| Total
Value |
$35,622 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aldeyra Therapeutics, Inc. |
ALDX |
Chief Financial Officer |
2017-12-29 |
8,563 |
2017-02-17 |
0 |
Premium* |
|
|
Stoke Therapeutics, Inc. |
STOK |
|
2024-03-19 |
20,746 |
2020-11-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2024-03-19 |
4 |
S |
$6.10 |
$25,102 |
D/D |
(4,116) |
20,746 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,100 |
24,862 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2022-06-02 |
4 |
OE |
$4.48 |
$49,997 |
D/D |
11,160 |
11,762 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2021-02-23 |
4 |
AS |
$58.60 |
$292,992 |
D/D |
(5,000) |
602 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2021-02-23 |
4 |
OE |
$4.48 |
$22,400 |
D/D |
5,000 |
5,602 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2021-02-22 |
4 |
OE |
$4.48 |
$112,000 |
D/D |
25,000 |
25,602 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2021-02-22 |
4 |
AS |
$58.67 |
$1,472,904 |
D/D |
(25,000) |
602 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2020-11-04 |
4 |
AS |
$40.03 |
$1,357,210 |
D/D |
(33,268) |
602 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2020-11-04 |
4 |
OE |
$4.48 |
$149,041 |
D/D |
33,268 |
33,870 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2020-11-03 |
4 |
AS |
$39.84 |
$68,998 |
D/D |
(1,732) |
602 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2020-11-03 |
4 |
OE |
$4.48 |
$7,759 |
D/D |
1,732 |
2,334 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2020-11-02 |
4 |
AS |
$36.79 |
$1,303,731 |
D/D |
(35,000) |
602 |
0 |
- |
|
| STOK |
Stoke Therapeutics, Inc. |
CFO |
• – – |
2020-11-02 |
4 |
OE |
$4.48 |
$156,800 |
D/D |
35,000 |
35,602 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-12-29 |
4 |
A |
$4.00 |
$12,596 |
D/D |
3,153 |
8,563 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-06-30 |
4 |
A |
$3.95 |
$8,209 |
D/D |
2,077 |
5,410 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
Chief Financial Officer |
• – – |
2017-02-17 |
4 |
B |
$4.50 |
$14,999 |
D/D |
3,333 |
3,333 |
2.74 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
